Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: Azure, a Randomized Trial of Treat-And-Extend Vs. Fixed Dosing

AuthID
P-00Z-QSC
10
Author(s)
Kodjikian, L
·
Barquet, LA
·
Papp, A
·
Kertes, PJ
·
Midena, E
·
Ernest, J
·
Schmelter, T
·
Niesen, T
·
Leal, S
Tipo de Documento
Article in Press
Year published
2024
Publicado
in ADVANCES IN THERAPY, ISSN: 0741-238X
Volume: 41, Número: 3, Páginas: 1010-1024 (15)
Indexing
Publication Identifiers
Pubmed: 38183525
SCOPUS: 2-s2.0-85181530426
Wos: WOS:001137206300002
Source Identifiers
ISSN: 0741-238X
Export Publication Metadata
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.